Trial Condition(s):

Diagnostic Imaging, Heart Defects, Congenital

Dose finding study with SH U 454 as an echocardiographic contrast agent for clarification of congenital malformations involving the right heart in patients from 0 - 18 years

Bayer Identifier:

Trial_85236

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

August1986

December1988

Phase

Could I receive a placebo?

Products

Echovist (α-D-Galactose, BAY86-4872)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Diagnostic Imaging, Heart Defects, Congenital

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

1 Days

18 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information